Polystyrene Family Polymers for Drug Delivery

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce the availability of Polystyrene Family polymers for a variety of drug delivery applications. These polymers offer tunable physicochemical properties that enable sustained release profiles and improved drug bioavailability. The polystyrene family, a group of polymers derived from the styrene monomer, has attracted considerable interest in the field of drug delivery due to its versatility of properties and applications. Polystyrene consists of both homopolymers and copolymers that offer a wide range of options for customizing drug delivery systems to meet specific therapeutic needs. CD Bioparticles is committed to providing researchers with the tools they need to develop new and effective drug delivery systems. Recognizing the immense potential of the polystyrene family, CD Bioparticles is expanding its low PDI polymer portfolio to offer a variety of polystyrene family polymers with different molecular weights and surface properties to meet the specific needs of each drug delivery application. The company’s polystyrene family polymers are a versatile platform for the design of drug carriers, offering several advantages. For example, the versatility of polystyrene is demonstrated by its ability to be modified for controlled drug release, bioadhesion and targeted drug delivery. The inert nature of polystyrene enhances drug stability and ensures the integrity of the drug formulation. In addition, polystyrene’s compatibility with a wide range of drugs and other materials allows the creation of versatile drug delivery platforms.